IFNGR1 and melanoma: Of note, although IFN-I was not required for the induction of resistance, it helped sustain ICB resistance, as additional IFNAR1 ablation on top of IFNGR1 deletion promoted a greater therapeutic response in ICB-resistant melanoma, as compared to IFNGR1 deletion alone.